Related Experiment Video
Updated: Aug 10, 2026
08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
HIV and refractory anemia with excess blasts (RAEB)
Geoffrey A Modest1, Timothy P Cooley, Jeff F Zacks
1Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts, USA. gmodest@partners.org
American Journal of Hematology
|September 5, 2002
Summary
A 36-year-old man with pneumonia and myelodysplastic syndrome, a bone marrow disorder, also had advanced HIV infection. Both conditions improved with highly active anti-retroviral therapy (HAART).
Area of Science:
- Hematology
- Infectious Diseases
- Oncology
Background:
- Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
- Pneumonia can be a serious complication in immunocompromised patients.
- Human Immunodeficiency Virus (HIV) infection can lead to various hematologic abnormalities.
Observation:
- A 36-year-old male presented with pneumonia and pancytopenia.
- Bone marrow biopsy confirmed refractory anemia with excess blasts, indicative of myelodysplastic syndrome.
- Advanced HIV infection was diagnosed concurrently.
Findings:
- Treatment with highly active anti-retroviral therapy (HAART) led to a response in both HIV infection and myelodysplastic syndrome.
- Hematologic abnormalities, including anemia and pancytopenia, showed sustained normalization within 79 days.
- This suggests a potential link or shared pathway between HIV and MDS in this patient.
Implications:
- HAART may have a beneficial effect on certain myelodysplastic syndromes in HIV-positive individuals.
- Further research is warranted to explore the interaction between HIV and MDS.
- This case highlights the importance of comprehensive evaluation in patients presenting with cytopenias and infections.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:19Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...